Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Refractory Chronic Cough, Unexplained Chronic Cough, Cough Hypersensitivity
Interventions: Cough Management, CoughMonitor Suite; Behavioral · Device
Lead sponsor: Hyfe Inc; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Aging, Emergencies
Interventions: PA4LE Program; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 55 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: CAPTURE Tool; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 45 Years to 80 Years
Enrollment: 4,679 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 8
States / cities: Los Angeles, California • Aurora, Colorado • Miami, Florida + 4 more

Conditions: Depression
Interventions: MoodHelper Internet program for Depression Self-Help; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 14 Years to 24 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Chronic Plaque-type Psoriasis
Interventions: Skin biopsies; Procedure
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 4
States / cities: New Orleans, Louisiana • East Windsor, New Jersey • Philadelphia, Pennsylvania + 1 more

Conditions: Hot Flashes, Postmenopausal Symptoms, Breast Cancer
Interventions: Self-Administered Hypnosis, Self-Administered White Noise Hypnosis; Behavioral
Lead sponsor: Baylor University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Waco, Texas

Conditions: Psychological Distress
Interventions: acceptance and commitment therapy (ACT), Control group; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Post Traumatic Stress Disorder
Interventions: Prolonged Exposure for Primary Care (PE-PC), EAP Treatment as Usual (TAU); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 14
States / cities: San Diego, California • Carrollton, Georgia • Ann Arbor, Michigan + 9 more

Conditions: Gastroparesis, Gastroesophageal Reflux
Interventions: domperidone; Drug
Lead sponsor: David J. Lederer, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Alopecia Areata
Interventions: Abatacept; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
Interventions: NS-229, Placebo; Drug
Lead sponsor: NS Pharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Denver, Colorado • Rochester, Minnesota • Cleveland, Ohio + 4 more

Conditions: Phenylketonuria
Interventions: BMN 165; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 31
States / cities: La Jolla, California • Oakland, California • Aurora, Colorado + 28 more

Conditions: Symptom Management, Reduce Treatment Non-adherence
Interventions: Assessment only group, Intervention group; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Androgenetic Alopecia
Interventions: Handi-Dome Laser, Incandescent red light source.; Device
Lead sponsor: Capillus, LLC; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 2
States / cities: Great Neck, New York • Woodbury, New York

Conditions: Spinal Cord Injuries
Interventions: WOWii (Workout on Wheels Internet Intervention); Behavioral
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Heart Transplant
Interventions: Evolocumab; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 80 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Chronic Stroke
Interventions: Vagus Nerve Stimulation (VNS) Device, Sham VNS Device, Upper Extremity Rehabilitation; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 22 Years to 79 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New York, New York • Richardson, Texas

Conditions: Opioid Use Disorder (OUD)
Interventions: Observational study with MRI/EEG; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 21 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Autobiographical Memory, Function of the Human Hippocampus
Interventions: Participants use a smartphone to replay self-generated autobiographical memory cues.; Other
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Injury, Inflammation
Interventions: dicreatinol sulfate, placebo sugar pill; Dietary Supplement · Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 25 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Medical Conditions
Interventions: Web-SUCCEED; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 396 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prediabetes
Interventions: Diabetes Prevention Program (DPP), Produce Prescription Plan (PPP); Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Hypertension
Interventions: SERVE OC Intervention, Enhanced Standard Intervention; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 5 Years and older
Enrollment: 483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
Interventions: Mirvetuximab Soravtansine, Lubricating Eye Drops, Prednisolone acetate ophthalmic suspension 1% eye drops, Brimonidine tartrate ophthalmic solution eye drops; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 13
States / cities: Los Angeles, California • San Francisco, California • Louisville, Kentucky + 9 more

Search by objective public record fields.

Cough Management Wellness App for Refractory or Unexplained Chronic Cough

Preventing Avoidable Admissions Among Assisted Living Elders

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)

Study of a Self-Help Depression Skills Program for College-Aged Youth

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

A Mind-Body Intervention for Hot Flash Management

Guided Eight-week Online Acceptance and Commitment Therapy for Distressed Family Caregivers of People With Dementia

Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

Domperidone for Gastroparesis in Solid Organ Transplantation

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165

Project Persist: mHealth for Cancer Survivorship

A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy

Workout on Wheels Internet Intervention (WOWii)

Impact of Evolocumab in Cardiac Transplant Patients With CAV

Paired Vagus Nerve Stimulation Mechanisms

Mapping Ibogaine Neural Dynamics in Opioid Use Disorder

fMRI Studies of Memory and Perception

Nutritional Supplement, Eccentric Exercise and Recovery

Web-based Program to Improve Self-management Among Veterans-caregiver Dyads

Integrating a Prescription Produce Program Within a Diabetes Prevention Program

Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression